Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>Accurately predicting the risk of death, recurrence, and metastasis of patients with nasopharyngeal carcinoma (NPC) is potentially important for personalized diagnosis and treatment. Survival outcomes of patients vary greatly in distinct stages of NPC. Prognostic models of stratified patients may aid in prognostication.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Purpose</h3><p>To explore the prognostic performance of MRI‐based radiomics signatures in stratified patients with NPC.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Study Type</h3><p>Retrospective.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Population</h3><p>Seven hundred and seventy‐eight patients with NPC (T1‐2 stage: 298, T3‐4 stage: 480; training cohort: 525, validation cohort: 253).</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Field Strength/Sequence</h3><p>Fast‐spin echo (FSE) axial T1‐weighted images, FSE axial T2‐weighted images, contrast‐enhanced FSE axial T1‐weighted images at 1.5 T or 3.0 T.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Assessment</h3><p>Radiomics signatures, clinical nomograms, and radiomics nomograms combining the radiomic score (Radscore) and clinical factors for predicting progression‐free survival (PFS) were constructed on T1‐2 stage patient cohort (A), T3‐4 stage patient cohort (B), and the entire dataset (C).</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Statistical Tests</h3><p>Least absolute shrinkage and selection operator (LASSO) method was applied for radiomics modeling. Harrell's concordance indices (C‐index) were employed to evaluate the predictive power of each model.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>Among 4,410 MRI‐extracted features, we selected 16, 16, and 14 radiomics features most relevant to PFS for Models A, B, and C, respectively. Only 0, 1, and 4 features were found overlapped between models A/B, A/C, and B/C, respectively. Radiomics signatures constructed on T1‐2 stage and T3‐4 stage patients yielded C‐indices of 0.820 (95% confidence interval [CI]: 0.763–0.877) and 0.726 (0.687–0.765), respectively, which were larger than those on the entire validation cohort (0.675 [0.637–0.713]). Radiomics nomograms combining Radscore and clinical factors achieved significantly better performance than clinical nomograms (<i>P</i> < 0.05 for all). </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Data Conclusion</h3><p>The selected radiomics features and prognostic performance of radiomics signatures differed per the type of NPC patients incorporated into the models. Radiomics models based on pre‐stratified tumor stages had better prognostic performance than those on unstratified dataset.</p><p><b>Level of Evidence</b>: 4 </p><p><b>Technical Efficacy Stage</b>: 5 </p></section>

Demonstration of Sub-Millimeter Wave Fundamental Oscillators Using 35-nm InP HEMT Technology

Differences in Radiomics Signatures Between Patients with Early and Advanced T‐Stage Nasopharyngeal Carcinoma Facilitate Prognostication

Radiomics Nomogram Based on Multiple-Sequence Magnetic Resonance Imaging Predicts Long-Term Survival in Patients Diagnosed With Nasopharyngeal Carcinoma

MRI-based Radiomics Signature is a Quantitative Prognostic Biomarker for Nasopharyngeal Carcinoma

MRI-based radiomics models can improve prognosis prediction for nasopharyngeal carcinoma with neoadjuvant chemotherapy

Magnetic resonance imaging-based radiogenomics analysis for predicting prognosis and gene expression profile in advanced nasopharyngeal carcinoma

Incremental Change: The Pace of Progress in Health

Dynamic Contrast-Enhanced Magnetic Resonance Imaging-Based Radiomics for the Prediction of Progression-Free Survival in Advanced Nasopharyngeal Carcinoma

Subregional Radiomics Analysis of PET/CT Imaging with Intratumor Partitioning: Application to Prognosis for Nasopharyngeal Carcinoma

Integration of MRI-Based Radiomics Features, Clinicopathological Characteristics, and Blood Parameters: A Nomogram Model for Predicting Clinical Outcome in Nasopharyngeal Carcinoma

Multimodality radiomics for tumor prognosis in nasopharyngeal carcinoma

The Effect of Magnetic Resonance Imaging Based Radiomics Models in Discriminating stage I–II and III–IVa Nasopharyngeal Carcinoma

Prognostic value of PET/CT and MR-based baseline radiomics among patients with non-metastatic nasopharyngeal carcinoma

Comprehensive integrated analysis of MR and DCE-MR radiomics models for prognostic prediction in nasopharyngeal carcinoma

A Clinical-Radiomics Nomogram Based on Magnetic Resonance Imaging for Predicting Progression-Free Survival After Induction Chemotherapy in Nasopharyngeal Carcinoma

Nomograms based on multiparametric MRI radiomics integrated with clinical-radiological features for predicting the response to induction chemotherapy in nasopharyngeal carcinoma

Radiomics Analysis of PET and CT Components of PET/CT Imaging Integrated with Clinical Parameters: Application to Prognosis for Nasopharyngeal Carcinoma

A deep learning MR-based radiomic nomogram may predict survival for nasopharyngeal carcinoma patients with stage T3N1M0

Radiomic signatures associated with tumor immune heterogeneity predict survival in locally recurrent nasopharyngeal carcinoma

Use of Radiomics Combined With Machine Learning Method in the Recurrence Patterns After Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma: A Preliminary Study.

Prediction of 5-year Progression-Free Survival in Advanced Nasopharyngeal Carcinoma with Pretreatment PET/CT using Multi-Modality Deep Learning-based Radiomics